Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia-Reference-Cited by-同舟云学术

Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia

Published:2003-04 Issue:6 Volume:114 Page:485-494
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Blake Gavin J,Ridker Paul M,Kuntz Karen M

Publisher

Elsevier BV

Subject

General Medicine

Reference42 articles.

1. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995

2. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels;Downs;JAMA,1998

3. Using cost-effectiveness analysis to target cholesterol reduction;Garber;Ann Intern Med,2000

4. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial;Kuller;Am J Epidemiol,1996

5. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men;Ridker;N Engl J Med,1997

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triglycerides and Residual Atherosclerotic Risk;Journal of the American College of Cardiology;2021-06

2. Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature;The European Journal of Health Economics;2015-12-18

3. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States;International Journal of Cardiology;2015-02

4. Chinese Yam Extracts Containing β-Sitosterol and Ethyl Linoleate Protect against Atherosclerosis in Apolipoprotein E-Deficient Mice and Inhibit Muscular Expression of VCAM-1In Vitro;Journal of Food Science;2014-04

5. C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction;New England Journal of Medicine;2012-10-04